LevinPro HC Stat of the Week, October 31, 2025

What Physician Specialties Are Private Equity Firms After? *This data includes any physician specialty with less than 2% of overall deal activity Editor’s Commentary: Throughout 2025, dental practices have been the clear favorite for roll-up acquisitions by private equity firms and their sponsored platforms. This year’s trend mirrors activity we captured in 2024 and 2023 on our LevinPro HC platform, with dental drawing most of the attention in private equity investments and funding for years now. The volume of activity makes sense when you examine the tailwinds: a fragmented market, stable cash flows and the promise of a DSO’s ability to generate higher margins at scale.... Read More »
PE-Backed BioMatrix Infusion Pharmacy Closes Acquisition of LUX Infusion

PE-Backed BioMatrix Infusion Pharmacy Closes Acquisition of LUX Infusion

BioMatrix Infusion Pharmacy, backed by private equity firm Frazier Healthcare Partners, announced the successful acquisition of LUX Infusion, effective October 17, 2025. With this acquisition, BioMatrix extends its reach into the Pacific Northwest. Financial terms of the deal were not disclosed. LUX Infusion is Alaska’s leading independent ambulatory infusion provider, offering safe, convenient and cost-effective care for patients with acute and chronic conditions. The company has three locations across the state. Headquartered in Plantation, Florida, BioMatrix Infusion Pharmacy is a nationwide, independent specialty infusion pharmacy. Frazier Healthcare Partners acquired the company... Read More »
TUSK Practice Sales Advises A Beautiful Smile in MB2 Dental Transaction 

TUSK Practice Sales Advises A Beautiful Smile in MB2 Dental Transaction 

TUSK Practice Sales, a healthcare-focused M&A advisory firm, announced that it represented a dental practice in a recent transaction. The firm advised A Beautiful Smile on its acquisition by MB2 Dental Solutions.  A Beautiful Smile is based in Jacksonville, North Carolina. According to its website, there are two physicians on staff: Dr. Gina Collins Mancini and Dr. Whitney Mitchell.  MB2 Dental Solutions, a portfolio company of middle-market private equity firm Charlesbank Capital Partners since February 2021, partners with dentists and specialists. Founded in 2007, MB2 offers general dentistry services, orthodontics, cosmetic dentistry and oral surgery. In November 2024, Warburg... Read More »
Blackstone and TPG Acquire Hologic in $18.3 Billion Deal 

Blackstone and TPG Acquire Hologic in $18.3 Billion Deal 

On October 20, TPG and Blackstone announced that they entered into a definitive agreement to acquire Hologic, Inc. The purchase represents an enterprise value of up to $18.3 billion.  Founded in 1985, Hologic develops, manufactures and sells premium diagnostic products, medical imaging systems and surgical products, primarily for women’s health. Hologic reported an annual revenue of more than $4 billion for its 2024 fiscal year, which ended on September 28, 2024.  TPG is a global alternative asset management firm. It was founded in San Francisco in 1992 and has $246 billion of assets under management.  Blackstone is the world’s largest alternative asset manager. The... Read More »
U.S. Urology Partners Acquires New Jersey Urology Assets 

U.S. Urology Partners Acquires New Jersey Urology Assets 

U.S. Urology Partners, a portfolio company of General Atlantic, announced that it acquired the central and south divisions of New Jersey Urology.   New Jersey Urology central and south divisions include more than 20 locations in Atlantic, Burlington, Camden, Cumberland, Gloucester, Mercer, Middlesex, Monmouth and Somerset Counties. It also includes locations in Bucks County, Pennsylvania. New Jersey Urology has more than 22 locations and 60 physicians. The business was previously affiliated with Summit Health.  U.S. Urology Partners provides management expertise and infrastructure resources across several areas, including provider recruitment, payor contracting, data analytics and... Read More »
Private Equity Interest on the Rise in Q3:25

Private Equity Interest on the Rise in Q3:25

In the third quarter of 2025, private equity firms and their sponsored companies (“PE Buyers,” collectively) announced 183 transactions in the healthcare M&A market, or approximately 34.4% of all the 532 announced healthcare deals, according to data captured in the LevinPro HC platform. This represents an increase in M&A volume from the 148 PE transactions announced in the second quarter of 2025, yet activity is on par with the 182 deals reported in Q3:24. In Q3:25, disclosed spending totaled nearly $7.4 billion across 12 deals with a PE Buyer, averaging about $616 million per deal. The transaction with the largest purchase price was Patient Square Capital’s acquisition of Premier,... Read More »